Antibody Treatment for Advanced Celiac Disease

NCT01893775 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

NIH

Sponsor class

Conditions

Celiac Disease
Celiac Sprue
Gluten Enteropathy
Gluten-Sensitive Enteropathy

Interventions

BIOLOGICAL: Hu-Mik- Beta-1

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]